Navigation Links
Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer
Date:12/11/2009

REDWOOD CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009. The tender offer, which was previously scheduled to expire at 12:00 midnight, New York City time, on Friday, December 11, 2009, will be extended until 5:00 p.m., New York City time, on Wednesday, December 23, 2009. The tender offer remains subject to all previously announced terms and conditions.

As of 5:00 p.m., New York City time, on Thursday, December 10, 2009, 687,535 shares of common stock have been tendered pursuant to the offer.

IMPORTANT NOTICE: On November 13, 2009, Maxygen commenced a modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock. This press release is for informational purposes only and is neither an offer to buy nor the solicitation of an offer to sell any shares of Maxygen's common stock. The tender offer is being made solely by the offer to purchase, the related letter of transmittal and other related documents that Maxygen has previously sent to its stockholders. The materials have been filed as exhibits to Maxygen's tender offer statement on Schedule TO, which was originally filed with the Securities and Exchange Commission on November 13, 2009 (as subsequently amended or supplemented to date). These tender offer materials contain important information that investors are urged to read carefully before making any decision with respect to the tender offer. Each of these documents has been or will be filed with the Securities and Exchange Commission, and investors may obtain them
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock
2. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
3. Boston Scientific Announces Pricing of $2 Billion of Senior Notes
4. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
5. RetireSafe Announces Intention to Key Vote Senator Dorgans Drug Importation Amendment (SA 2793)
6. Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
7. Neogen Corporation Announces 2nd Quarter Results
8. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
9. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
10. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
11. Vivakor Announces New Acquisition Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  Seeger Weiss LLP is reporting that ... commence October 13, 2015. Since the ... approval program, Zimmer NexGen knee implant surpassed FDA investigation ... companies provide evidence that the product is substantially similar ... gain permissions. In 2001, Zimmer began ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ) ... Introduction to Medical Device Software: Regulations and Requirements ... to their offering. This course ... and requirements that apply to Medical Device Software. ... life examples and state-of- the-art practices identified from ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... of the "Medical Device Studies: Clinical Evidence ... to their offering. This course ... involved in gathering clinical evidence required for medical ... required for all medical devices and the emphasis ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... 7, 2011 Vystar® Corporation (OTCBB:VYST), ... Latex (NRL), a patented, all-natural raw latex material ... found in natural rubber latex, has appointed Joanne ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney is a ...
... ATLANTA, April 7, 2011 Harriet Robinson, Ph.D., ... provide an update on the status of the Company,s therapeutic ... at the Gaylord National Hotel and Convention Center in Washington ... will run from 11:30 – 11:50 a.m., will cover the ...
Cached Medicine Technology:Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
(Date:9/2/2015)... ... September 02, 2015 , ... ... patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions ... Series. The series enables pharmaceutical researchers to participate in interactive programs in ...
(Date:9/2/2015)... ... 02, 2015 , ... RxNT , an innovative software ... enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks ... leader in health technology, RxNT was one of the first to build an ...
(Date:9/2/2015)... Covington, LA (PRWEB) , ... September 02, 2015 ... ... new President/CEO and Regulatory Affairs Officer following the departure of Kristen Dietz, former ... Medical Officer of Healtec® released the following statement welcoming Mr. Salot: “ Stanley ...
(Date:9/2/2015)... ... 02, 2015 , ... Splashtop Inc., the worldwide leader in ... mirroring and extending product line -- Splashtop Wired XDisplay . Complementing ... setting, the new Splashtop Wired XDisplay delivers enhanced performance and reliability for users ...
(Date:9/2/2015)... ... September 02, 2015 , ... Care Providers and their ... documents that include EOBs, payments, and payment related documents. AD-EOB A/R helps them ... reconcile their billing, with one efficient process and interface,“ stated Rich Caproni, AliusDoc’s ...
Breaking Medicine News(10 mins):Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:Healtec® Announces Executive Leadership Change 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2
... A North Carolina team of doctors, nurses, hospitals and ... way to provide faster, more effective treatment for heart ... or fancy new equipment. But it does require competitors ... to move treatment forward empowering emergency services personnel ...
... condition, which is symptomless, can lead to heart attack ... More American women are suffering from asymptomatic peripheral artery ... risk for heart attack and stroke, a new study ... of an increase in common cardiovascular risk factors, namely ...
... from union benefit funds,Union coalition says Rite Aid wants union money, but ... ... They are telling conference attendees: Trust Rite Aid? Think Twice!, ... pharmacy benefits management company (Rite Aid,Solutions) at the International Foundation Employee Benefits ...
... TARRYTOWN, N.Y., Nov. 3 EpiCept Corporation,(Nasdaq and OMX ... a,conference call to discuss third quarter 2007 results and ... 8:30 a.m. EST. EpiCept,will release results for the three ... EST on Monday, November 5, 2007. (Logo: ...
... is disappointed with today,s ruling and we intend to ... at issue was the result of,highly competitive conditions in ... ruling on liability is thus profoundly,anti- competitive. AstraZeneca ... drugs and we firmly believe that we have acted ...
... Mexican Red Cross for Flood,Relief, WASHINGTON, Nov. 2 ... to provide $50,000 to the Mexican Red Cross to,assist ... than,800,000 people. Unusually heavy rains caused rivers to overflow ... was already waterlogged,after Hurricanes Dean and Felix., "Thousands ...
Cached Medicine News:Health News:RACE: a statewide model of better, faster heart attack care 2Health News:RACE: a statewide model of better, faster heart attack care 3Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 2Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 3Health News:Rite Aid's Fledgling Benefits Management Firm Hits Turbulence at Employee Benefits Conference in Anaheim 2Health News:EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007 2Health News:EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007 3Health News:Sister Red Cross Societies Help Each Other 2
... contemporary reading card was designed by James ... of near point exercises including words, numbers ... 20/260, 20/200, 20/100, 20/65, 20/50, 20/40, 20/30, ... reading in English and metric, Jaeger, point ...
Standard reading test. "walked regularly..."...
Standard reading test. "Children should be..."...
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
Medicine Products: